Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,590.00
-20.00 (-0.36%)
At close: Sep 11, 2026

Daehan Nupharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
15,25119,96629,72619,20221,15615,303
Short-Term Investments
1,0001,0008201,8201,494820
Trading Asset Securities
26,86512,0376,9712,7586,7206,197
Cash & Short-Term Investments
43,11733,00337,51723,78029,37022,319
Cash Growth
80.43%-12.03%57.77%-19.03%31.59%5.38%
Accounts Receivable
30,95431,33334,03735,10832,95026,510
Other Receivables
6,8806,6844,9353,5522,5543,408
Receivables
38,88339,06739,67239,95937,10431,878
Inventory
44,10941,07637,21532,89030,44820,391
Prepaid Expenses
22.31141.0572.8182.753,64353.85
Other Current Assets
716.45606.21877.531,7732,0771,391
Total Current Assets
126,848113,893115,35498,485102,64176,033
Property, Plant & Equipment
138,563133,29085,04254,31346,97846,294
Long-Term Investments
13,41718,65917,87421,42018,04220,513
Other Intangible Assets
1,1441,6371,122563.83336.14423.59
Long-Term Deferred Tax Assets
281.142,9461,1641,418594.4310,327
Other Long-Term Assets
945.74759.52729.93727.64767.444,052
Total Assets
281,199271,184221,285176,927169,359157,643

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
10,07714,99912,56910,23011,6338,179
Accrued Expenses
7,6788,9798,2487,4966,6085,787
Short-Term Debt
45,99043,87839,65535,67220,52315,812
Current Portion of Long-Term Debt
1,500---13,4614,700
Current Portion of Leases
547.33586.59531.14556.37426.7442.09
Current Income Taxes Payable
22.27418.62,2321,988-4,180
Other Current Liabilities
6,1944,5108,6465,8155,9325,948
Total Current Liabilities
72,00873,37171,88161,75858,58445,049
Long-Term Debt
58,12554,08718,831-2,00615,631
Long-Term Leases
287.51404.74409.87369.21226.1335.16
Pension & Post-Retirement Benefits
1,2392,7684,0624,7614,9314,792
Other Long-Term Liabilities
595.76605.05662.14682.91653.179,371
Total Liabilities
132,255131,23595,84667,57166,40075,178

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,1777,1777,1777,1777,1777,177
Additional Paid-In Capital
55,67655,67655,67655,67655,67655,676
Retained Earnings
81,05268,19454,49741,11230,6097,336
Treasury Stock
-3,075-3,075-3,075-3,075-3,075-3,075
Comprehensive Income & Other
8,11311,97611,1638,46612,57215,351
Shareholders' Equity
148,943139,949125,439109,356102,95982,465
Total Liabilities & Equity
281,199271,184221,285176,927169,359157,643

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
106,45098,95659,42736,59836,64236,920
Net Cash (Debt)
-63,333-65,953-21,910-12,818-7,272-14,601
Net Cash Growth
------
Net Cash Per Share
--4699.10-1561.08-913.25-518.12-1040.30
Filing Date Shares Outstanding
-14.0414.0414.0414.0414.04
Total Common Shares Outstanding
-14.0414.0414.0414.0414.04
Working Capital
54,84040,52343,47336,72744,05830,984
Book Value Per Share
-9971.218937.397791.507335.725875.57
Tangible Book Value
147,800138,312124,317108,792102,62382,042
Tangible Book Value Per Share
-9854.568857.497751.327311.775845.39
Land
13,77613,77613,58913,02113,02112,938
Buildings
42,99842,78443,39140,51832,67632,734
Machinery
40,87232,63131,09530,10726,97425,859
Construction In Progress
77,81278,80829,9481,1432,366179.45